<--- Back to Details
First PageDocument Content
Immunosuppressants / Alexion Pharmaceuticals / Acquired hemolytic anemia / Patient safety / Hemolytic-uremic syndrome / Meningococcal disease / Adverse effect / Meningococcal vaccine / Hus / Medicine / Health / Eculizumab
Date: 2014-10-08 10:01:47
Immunosuppressants
Alexion Pharmaceuticals
Acquired hemolytic anemia
Patient safety
Hemolytic-uremic syndrome
Meningococcal disease
Adverse effect
Meningococcal vaccine
Hus
Medicine
Health
Eculizumab

Microsoft Word - soliris_dhcpl_lapds_155506-eng.doc

Add to Reading List

Source URL: www.hc-sc.gc.ca

Download Document from Source Website

File Size: 76,67 KB

Share Document on Facebook

Similar Documents

Vassar College Meningococcal Meningitis Facts Please keep for your records New York State Department of Health — Bureau of Communicable Disease Control / Meningococcal Disease

DocID: 1vdbA - View Document

Vassar College Meningococcal Meningitis Facts Please keep for your records New York State Department of Health — Bureau of Communicable Disease Control / Meningococcal Disease

DocID: 1tI29 - View Document

April 17, 2015 Memo of Support A.791/S.4324 An act to amend public health law in relation to requiring vaccination against meningococcal disease The NYS AAP, representing more than 4,100 pediatricians across New York Sta

DocID: 1sqGa - View Document

Medicine / Clinical medicine / Health / Meningococcal vaccines / Vaccination / RTT / Meningococcal disease / Sepsis / Meningitis / Neisseria meningitidis / Vaccine / Immunization

Meningitis Statement Georgia state law requires all students residing in University housing to receive information about meningococcal disease. Evidence suggests that college students are at an increased risk of contract

DocID: 1rsYu - View Document

Medicine / Bacteria / Microbiology / Meningococcal vaccines / Meningococcal disease / Sepsis / Vaccination / Neisseria meningitidis / Meningitis / Vaccine / NmVac4-A/C/Y/W-135

New York State Department of Health

DocID: 1rfHH - View Document